Change Healthcare Inc. (CHNG)
Change Healthcare Statistics
Share Statistics
Change Healthcare has 0 shares outstanding. The number of shares has increased by 2.71% in one year.
Shares Outstanding | 0 |
Shares Change (YoY) | 2.71% |
Shares Change (QoQ) | 2.26% |
Owned by Institutions (%) | n/a |
Shares Floating | 249.5M |
Failed to Deliver (FTD) Shares | - |
FTD / Avg. Volume | < 0.01% |
Short Selling Information
Short Interest | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is -45.68 and the forward PE ratio is null. Change Healthcare's PEG ratio is -1.23.
PE Ratio | -45.68 |
Forward PE | n/a |
PS Ratio | 2.03 |
Forward PS | n/a |
PB Ratio | 2.16 |
P/FCF Ratio | 16.79 |
PEG Ratio | -1.23 |
Enterprise Valuation
Change Healthcare has an Enterprise Value (EV) of 11.47B.
EV / Sales | 3.3 |
EV / EBITDA | 12.65 |
EV / EBIT | 16.47 |
EV / FCF | 27.28 |
Financial Position
The company has a current ratio of 1.22, with a Debt / Equity ratio of 1.42.
Current Ratio | 1.22 |
Quick Ratio | 1.22 |
Debt / Equity | 1.42 |
Debt / EBITDA | 5.14 |
Debt / FCF | 11.09 |
Interest Coverage | 0.96 |
Financial Efficiency
Return on Equity is -4.72% and Return on Invested Capital is 4.14%.
Return on Equity | -4.72% |
Return on Assets | -1.56% |
Return on Invested Capital | 4.14% |
Revenue Per Employee | $248.63K |
Profits Per Employee | $-11.04K |
Employee Count | 14,000 |
Asset Turnover | 0.35 |
Inventory Turnover | n/a |
Taxes
Income Tax | 48.61M |
Effective Tax Rate | -45.86% |
Stock Price Statistics
The stock price has increased by null% in the last 52 weeks. The beta is 1.02, so Change Healthcare's price volatility has been higher than the market average.
Beta | 1.02 |
52-Week Price Change | null% |
50-Day Moving Average | 25.18 |
200-Day Moving Average | null |
Relative Strength Index (RSI) | 82.66 |
Average Volume (20 Days) | - |
Income Statement
In the last 12 months, Change Healthcare had revenue of 3.48B and earned -154.61M in profits. Earnings per share was -0.48.
Revenue | 3.48B |
Gross Profit | 3.48B |
Operating Income | 225.47M |
Net Income | -154.61M |
EBITDA | 907.27M |
EBIT | 128.24M |
Earnings Per Share (EPS) | -0.48 |
Balance Sheet
The company has 252.3M in cash and 4.66B in debt, giving a net cash position of -4.41B.
Cash & Cash Equivalents | 252.3M |
Total Debt | 4.66B |
Net Cash | -4.41B |
Retained Earnings | -1.1B |
Total Assets | - |
Working Capital | - |
Cash Flow
In the last 12 months, operating cash flow was 696.88M and capital expenditures -276.28M, giving a free cash flow of 420.6M.
Operating Cash Flow | 696.88M |
Capital Expenditures | -276.28M |
Free Cash Flow | 420.6M |
FCF Per Share | 1.3 |
Margins
Gross margin is 100%, with operating and profit margins of 6.48% and -4.44%.
Gross Margin | 100% |
Operating Margin | 6.48% |
Pretax Margin | -3.05% |
Profit Margin | -4.44% |
EBITDA Margin | 26.06% |
EBIT Margin | 6.48% |
FCF Margin | 12.08% |
Dividends & Yields
CHNG does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | -2.19% |
FCF Yield | 5.95% |
Analyst Forecast
Currently there are no analyst rating for CHNG.
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Scores
Altman Z-Score | null |
Piotroski F-Score | null |